1. Home
  2. WINA vs GENB Comparison

WINA vs GENB Comparison

Compare WINA & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$384.45

Market Cap

1.5B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$12.10

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WINA
GENB
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
WINA
GENB
Price
$384.45
$12.10
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.20
AVG Volume (30 Days)
69.0K
315.9K
Earning Date
04-15-2026
05-03-2026
Dividend Yield
3.55%
N/A
EPS Growth
3.76
N/A
EPS
2.50
N/A
Revenue
$86,055,700.00
N/A
Revenue This Year
$5.55
N/A
Revenue Next Year
$6.03
$45.45
P/E Ratio
$156.07
N/A
Revenue Growth
5.86
N/A
52 Week Low
$351.03
$11.00
52 Week High
$526.81
$14.21

Technical Indicators

Market Signals
Indicator
WINA
GENB
Relative Strength Index (RSI) 37.46 48.15
Support Level $368.70 $11.25
Resistance Level $387.52 $13.61
Average True Range (ATR) 21.98 0.95
MACD -4.62 0.00
Stochastic Oscillator 27.78 31.83

Price Performance

Historical Comparison
WINA
GENB

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: